M3 (OTCMKTS:MTHRF) Trading Up 1.7% – Time to Buy?

M3, Inc. (OTCMKTS:MTHRF) shares rose 1.7% on Monday . The stock traded as high as $14.00 and last traded at $14.00. Approximately 300 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 6,500 shares. The stock had previously closed at $13.76.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group cut shares of M3 to a “neutral” rating in a research report on Thursday, October 9th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

M3 Stock Up 1.7%

The business’s fifty day simple moving average is $14.12 and its 200 day simple moving average is $13.86.

About M3

M3, Inc is a Tokyo‐based company specializing in digital healthcare solutions and medical media platforms. Founded in 2000, the firm operates online networks that connect healthcare professionals with pharmaceutical and biotech companies, providing medical information, educational content and peer‐to‐peer communication tools. Over time, M3 has expanded its portfolio to encompass a broad range of services aimed at enhancing clinical decision‐making and streamlining drug development processes.

The company’s offerings include physician portals that deliver the latest research and treatment guidelines, digital marketing and e‐detailing services for life sciences companies, and real‐world evidence (RWE) analytics based on de-identified patient data.